Hyperglycemia, Reduced Hematopoietic Stem Cells, and Outcome of COVID-19.

Bonora, Benedetta Maria; Fogar, Paola; Zuin, Jenny; Falaguasta, Daniele; Cappellari, Roberta; Cattelan, Annamaria; Marinello, Serena; Ferrari, Anna; Avogaro, Angelo; Plebani, Mario; Basso, Daniela; Fadini, Gian Paolo

Bonora, Benedetta Maria; Fogar, Paola; Zuin, Jenny; Falaguasta, Daniele; Cappellari, Roberta; Cattelan, Annamaria; Marinello, Serena; Ferrari, Anna; Avogaro, Angelo; Plebani, Mario; Basso, Daniela; Fadini, Gian Paolo.

Afiliação

Bonora BM; Department of Medicine, University of Padova, Padua, Italy.
Fogar P; Veneto Institute of Molecular Medicine, Padua, Italy.
Zuin J; Department of Medicine, University of Padova, Padua, Italy.
Falaguasta D; Department of Medicine, University of Padova, Padua, Italy.
Cappellari R; Department of Medicine, University of Padova, Padua, Italy.
Cattelan A; Department of Medicine, University of Padova, Padua, Italy.
Marinello S; Department of Medicine, University of Padova, Padua, Italy.
Ferrari A; Department of Medicine, University of Padova, Padua, Italy.
Avogaro A; Department of Medicine, University of Padova, Padua, Italy.
Plebani M; Department of Medicine, University of Padova, Padua, Italy.
Basso D; Department of Medicine, University of Padova, Padua, Italy.
Fadini GP; Department of Medicine, University of Padova, Padua, Italy.

Diabetes ; 71(4): 788-794, 2022 04 01.

Article em En | MEDLINE | ID: mdl-35061020

Assuntos

COVID-19; Hiperglicemia; Antígenos CD34/metabolismo; Citometria de Fluxo; Células-Tronco Hematopoéticas/metabolismo; Humanos; Hiperglicemia/metabolismo

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 4_TD / 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Assunto principal: COVID-19 / Hiperglicemia Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Diabetes Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google